

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.74924624 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.74924624 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.74924624 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.74924624 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.74924624 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.74924624 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.47983922 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28354948 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.75072076 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52359878 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52359878 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50371469 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36181463 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.34923183 |
| 15 | respiratory burst (GO:0045730) | 4.23301461 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.14400739 |
| 17 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.11552365 |
| 18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.10356716 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02546437 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99113706 |
| 21 | microglial cell activation (GO:0001774) | 3.95540136 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 3.93892702 |
| 23 | response to peptidoglycan (GO:0032494) | 3.83938288 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.82010569 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.81775856 |
| 26 | cellular extravasation (GO:0045123) | 3.78399958 |
| 27 | detection of other organism (GO:0098543) | 3.73184862 |
| 28 | glycosphingolipid catabolic process (GO:0046479) | 3.72840198 |
| 29 | negative regulation of granulocyte differentiation (GO:0030853) | 3.71350118 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.67600397 |
| 31 | response to host immune response (GO:0052572) | 3.66915514 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.66915514 |
| 33 | apoptotic cell clearance (GO:0043277) | 3.64387505 |
| 34 | detection of bacterium (GO:0016045) | 3.56009235 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55244734 |
| 36 | negative regulation of cell killing (GO:0031342) | 3.55244734 |
| 37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.53368217 |
| 38 | response to host (GO:0075136) | 3.47203201 |
| 39 | response to host defenses (GO:0052200) | 3.47203201 |
| 40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.47203201 |
| 41 | pinocytosis (GO:0006907) | 3.43117641 |
| 42 | macrophage activation (GO:0042116) | 3.41948763 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.38293879 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.35265409 |
| 45 | glycolipid catabolic process (GO:0019377) | 3.33870244 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.27496355 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.27305034 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.24676339 |
| 49 | complement activation, alternative pathway (GO:0006957) | 3.22233025 |
| 50 | amino sugar catabolic process (GO:0046348) | 3.21939474 |
| 51 | oligosaccharide catabolic process (GO:0009313) | 3.21713050 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.18514667 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 3.18189422 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17016886 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.14317547 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09362728 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.05634643 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.05237518 |
| 59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04876241 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.03304930 |
| 61 | neutrophil activation (GO:0042119) | 3.03080375 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 3.02965857 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02151698 |
| 64 | regulation of apoptotic cell clearance (GO:2000425) | 3.01772911 |
| 65 | granulocyte activation (GO:0036230) | 3.01076916 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99157326 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 2.98821817 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 2.98821779 |
| 69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98598470 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97792448 |
| 71 | neutrophil mediated immunity (GO:0002446) | 2.97302002 |
| 72 | regulation of cholesterol storage (GO:0010885) | 2.96669902 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95951583 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 2.95526426 |
| 75 | detection of biotic stimulus (GO:0009595) | 2.95397506 |
| 76 | regulation of phagocytosis (GO:0050764) | 2.91852502 |
| 77 | ceramide catabolic process (GO:0046514) | 2.90065651 |
| 78 | response to protozoan (GO:0001562) | 2.89994464 |
| 79 | negative regulation of phagocytosis (GO:0050765) | 2.89907804 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89394464 |
| 81 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.89389218 |
| 82 | germinal center formation (GO:0002467) | 2.88488082 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 2.86064518 |
| 84 | positive regulation of interferon-beta production (GO:0032728) | 2.85918442 |
| 85 | cellular response to type I interferon (GO:0071357) | 2.84442170 |
| 86 | type I interferon signaling pathway (GO:0060337) | 2.84442170 |
| 87 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.83959360 |
| 88 | leukocyte aggregation (GO:0070486) | 2.83945655 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82314570 |
| 90 | response to type I interferon (GO:0034340) | 2.81893657 |
| 91 | regulation of mast cell activation (GO:0033003) | 2.81831253 |
| 92 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78674682 |
| 93 | leukotriene metabolic process (GO:0006691) | 2.78139604 |
| 94 | hyaluronan catabolic process (GO:0030214) | 2.76793467 |
| 95 | regulation of integrin activation (GO:0033623) | 2.76696238 |
| 96 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76537057 |
| 97 | B cell mediated immunity (GO:0019724) | 2.76055911 |
| 98 | barbed-end actin filament capping (GO:0051016) | 2.76049895 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.75264871 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74216356 |
| 101 | response to fungus (GO:0009620) | 2.72510175 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71254568 |
| 103 | regulation of mononuclear cell migration (GO:0071675) | 2.70883644 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.70606787 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.69540036 |
| 106 | response to thyroid hormone (GO:0097066) | 2.69334002 |
| 107 | N-acetylneuraminate metabolic process (GO:0006054) | 2.69288695 |
| 108 | I-kappaB phosphorylation (GO:0007252) | 2.68759119 |
| 109 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68252435 |
| 110 | * mannose metabolic process (GO:0006013) | 2.68224544 |
| 111 | leukocyte cell-cell adhesion (GO:0007159) | 2.66067107 |
| 112 | protein localization to endosome (GO:0036010) | 2.66005238 |
| 113 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.64692307 |
| 114 | response to laminar fluid shear stress (GO:0034616) | 2.63461225 |
| 115 | tolerance induction (GO:0002507) | 2.63322596 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 2.63263682 |
| 117 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61740340 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.61588013 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61297237 |
| 120 | positive thymic T cell selection (GO:0045059) | 2.60735704 |
| 121 | dendritic cell differentiation (GO:0097028) | 2.60601894 |
| 122 | myeloid leukocyte activation (GO:0002274) | 2.60200359 |
| 123 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59898340 |
| 124 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.58884133 |
| 125 | regulation of regulated secretory pathway (GO:1903305) | 2.58730682 |
| 126 | macrophage differentiation (GO:0030225) | 2.58729362 |
| 127 | T cell migration (GO:0072678) | 2.58593830 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.58494352 |
| 129 | low-density lipoprotein particle clearance (GO:0034383) | 2.58417987 |
| 130 | lipoxygenase pathway (GO:0019372) | 2.56000541 |
| 131 | keratan sulfate catabolic process (GO:0042340) | 2.54680692 |
| 132 | positive regulation of phagocytosis (GO:0050766) | 2.53925856 |
| 133 | neutrophil chemotaxis (GO:0030593) | 2.53559165 |
| 134 | complement activation (GO:0006956) | 2.53456851 |
| 135 | positive regulation of chemokine secretion (GO:0090197) | 2.53121947 |
| 136 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49999910 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49999093 |
| 138 | defense response to protozoan (GO:0042832) | 2.49426710 |
| 139 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.48927513 |
| 140 | neutrophil migration (GO:1990266) | 2.48426882 |
| 141 | regulation of macrophage chemotaxis (GO:0010758) | 2.47863416 |
| 142 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.47562850 |
| 143 | protein carboxylation (GO:0018214) | 2.47562850 |
| 144 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45805850 |
| 145 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45718141 |
| 146 | positive regulation of mast cell degranulation (GO:0043306) | 2.44883380 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.44883380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.15908289 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76304217 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.62991416 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83103462 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74430530 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43806369 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34840466 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.99744574 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99132541 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90263625 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.89528311 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79294309 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.73026770 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.69263495 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61844423 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.51331424 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46197742 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45591187 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37772181 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35122135 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32096067 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27601866 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24127810 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14415646 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05467477 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02440575 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99384515 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98378696 |
| 29 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91765441 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90976564 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.89432081 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.88586515 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86125576 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.85098410 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84936947 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77908038 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75957893 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74935887 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73549495 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70659890 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70323787 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68507655 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65778145 |
| 44 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64088386 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63471231 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.62805696 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61470649 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.61063085 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60890624 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57496537 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53628236 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51214370 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47912683 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45699958 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44287466 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43610466 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39343920 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36482884 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34474014 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32990748 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30732776 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30005815 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29717617 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29687892 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29287341 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23603836 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22815922 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22062777 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21742927 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21383513 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21034308 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20758310 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20079188 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19108533 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18322737 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17899067 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16864524 |
| 78 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16822133 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16144838 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15439941 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14646887 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14499079 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13933187 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13840954 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13754466 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12803688 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11856747 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11552009 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11366845 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11097392 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10439713 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08805304 |
| 93 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08277372 |
| 94 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.08200841 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07105847 |
| 96 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07010712 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06288405 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05782650 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03767055 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03703256 |
| 101 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02466713 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00946293 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00814948 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99699990 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99652616 |
| 106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98763390 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98059631 |
| 108 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.98028772 |
| 109 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95156413 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94927772 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94675541 |
| 112 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.88792569 |
| 113 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85525578 |
| 114 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.85285789 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80637144 |
| 116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80355860 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79372891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005058_abnormal_lysosome_morphology | 3.73542127 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.65648003 |
| 3 | MP0003436_decreased_susceptibility_to | 3.36277605 |
| 4 | MP0003303_peritoneal_inflammation | 3.25382501 |
| 5 | MP0002419_abnormal_innate_immunity | 2.89890107 |
| 6 | MP0006082_CNS_inflammation | 2.88454828 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.85585463 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.83394485 |
| 9 | MP0009840_abnormal_foam_cell | 2.77051113 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.52821789 |
| 11 | MP0005025_abnormal_response_to | 2.44967893 |
| 12 | MP0001790_abnormal_immune_system | 2.43143093 |
| 13 | MP0005387_immune_system_phenotype | 2.43143093 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.41639805 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.35013162 |
| 16 | MP0001800_abnormal_humoral_immune | 2.34619659 |
| 17 | MP0000685_abnormal_immune_system | 2.33812997 |
| 18 | MP0009785_altered_susceptibility_to | 2.29444598 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.29164154 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.27805340 |
| 21 | MP0003724_increased_susceptibility_to | 2.22757121 |
| 22 | MP0005671_abnormal_response_to | 2.20636353 |
| 23 | MP0002723_abnormal_immune_serum | 2.11215781 |
| 24 | MP0005451_abnormal_body_composition | 2.06123549 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.00630421 |
| 26 | MP0001819_abnormal_immune_cell | 2.00389233 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.99183174 |
| 28 | MP0002405_respiratory_system_inflammati | 1.75663475 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.73525293 |
| 30 | MP0004947_skin_inflammation | 1.69371783 |
| 31 | MP0008469_abnormal_protein_level | 1.63793602 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.62579850 |
| 33 | MP0008260_abnormal_autophagy | 1.57713666 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.56669079 |
| 35 | MP0003075_altered_response_to | 1.56304160 |
| 36 | MP0003690_abnormal_glial_cell | 1.55603118 |
| 37 | * MP0000716_abnormal_immune_system | 1.54423713 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.53529483 |
| 39 | * MP0000689_abnormal_spleen_morphology | 1.51827751 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.50863784 |
| 41 | MP0001853_heart_inflammation | 1.49809535 |
| 42 | MP0009278_abnormal_bone_marrow | 1.49320778 |
| 43 | MP0000343_altered_response_to | 1.49100421 |
| 44 | MP0000604_amyloidosis | 1.48608828 |
| 45 | MP0002398_abnormal_bone_marrow | 1.46777612 |
| 46 | MP0003828_pulmonary_edema | 1.42384747 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.42151908 |
| 48 | MP0005360_urolithiasis | 1.41788089 |
| 49 | MP0004510_myositis | 1.39021709 |
| 50 | MP0002722_abnormal_immune_system | 1.32665260 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.31604214 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.31196064 |
| 53 | MP0001873_stomach_inflammation | 1.31092406 |
| 54 | * MP0002429_abnormal_blood_cell | 1.29752372 |
| 55 | MP0005310_abnormal_salivary_gland | 1.29554275 |
| 56 | MP0008004_abnormal_stomach_pH | 1.29406264 |
| 57 | MP0001851_eye_inflammation | 1.29266521 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.27546551 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.26056773 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.25632262 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.25632262 |
| 62 | MP0002933_joint_inflammation | 1.21486366 |
| 63 | MP0003448_altered_tumor_morphology | 1.20287868 |
| 64 | MP0009764_decreased_sensitivity_to | 1.19023987 |
| 65 | MP0002006_tumorigenesis | 1.18963800 |
| 66 | MP0005166_decreased_susceptibility_to | 1.17448852 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.16707701 |
| 68 | MP0005365_abnormal_bile_salt | 1.13502181 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.12725552 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.12168871 |
| 71 | MP0003091_abnormal_cell_migration | 1.11728606 |
| 72 | MP0009763_increased_sensitivity_to | 1.10331240 |
| 73 | MP0000858_altered_metastatic_potential | 1.09640353 |
| 74 | MP0000609_abnormal_liver_physiology | 1.09617438 |
| 75 | MP0010329_abnormal_lipoprotein_level | 1.08392750 |
| 76 | MP0003329_amyloid_beta_deposits | 1.06958777 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.04707197 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.03525059 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 1.02192084 |
| 80 | MP0010307_abnormal_tumor_latency | 0.98757200 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.98374627 |
| 82 | MP0003279_aneurysm | 0.97990480 |
| 83 | MP0000249_abnormal_blood_vessel | 0.95156506 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.94961532 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.94801872 |
| 86 | MP0005023_abnormal_wound_healing | 0.93805728 |
| 87 | MP0004883_abnormal_blood_vessel | 0.93506991 |
| 88 | MP0003252_abnormal_bile_duct | 0.93032704 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.92102913 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.92010872 |
| 91 | MP0002254_reproductive_system_inflammat | 0.91532482 |
| 92 | MP0006054_spinal_hemorrhage | 0.91021789 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.89695135 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.89689425 |
| 95 | MP0001849_ear_inflammation | 0.88807561 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.87370463 |
| 97 | MP0005083_abnormal_biliary_tract | 0.87264649 |
| 98 | MP0000490_abnormal_crypts_of | 0.84393566 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82766924 |
| 100 | * MP0009643_abnormal_urine_homeostasis | 0.80667863 |
| 101 | MP0005085_abnormal_gallbladder_physiolo | 0.80346370 |
| 102 | * MP0000598_abnormal_liver_morphology | 0.80082073 |
| 103 | MP0001958_emphysema | 0.79997134 |
| 104 | MP0000920_abnormal_myelination | 0.79834315 |
| 105 | MP0001663_abnormal_digestive_system | 0.79440340 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.79215953 |
| 107 | * MP0005390_skeleton_phenotype | 0.78184027 |
| 108 | MP0003866_abnormal_defecation | 0.76272313 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75595243 |
| 110 | MP0003045_fibrosis | 0.74057801 |
| 111 | MP0005670_abnormal_white_adipose | 0.72868626 |
| 112 | MP0000371_diluted_coat_color | 0.72297498 |
| 113 | MP0005164_abnormal_response_to | 0.71356839 |
| 114 | MP0003795_abnormal_bone_structure | 0.70653685 |
| 115 | MP0008873_increased_physiological_sensi | 0.69349119 |
| 116 | MP0001542_abnormal_bone_strength | 0.69212835 |
| 117 | MP0005165_increased_susceptibility_to | 0.68569533 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.68428511 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.68407109 |
| 120 | MP0008874_decreased_physiological_sensi | 0.64660762 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.61085132 |
| 122 | MP0004858_abnormal_nervous_system | 0.57257660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.70505653 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.75674535 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.34804823 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16594605 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.16298176 |
| 6 | Glomerulonephritis (HP:0000099) | 4.93225062 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.89627360 |
| 8 | Complement deficiency (HP:0004431) | 4.34043654 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.26943538 |
| 10 | * Dysostosis multiplex (HP:0000943) | 4.25182343 |
| 11 | Mucopolysacchariduria (HP:0008155) | 4.18566707 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.18566707 |
| 13 | * Vacuolated lymphocytes (HP:0001922) | 4.14833336 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.06783375 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.05155718 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.05155718 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.05155718 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.96149481 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.96149481 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.96149481 |
| 21 | Abnormality of complement system (HP:0005339) | 3.94124946 |
| 22 | Recurrent skin infections (HP:0001581) | 3.39985477 |
| 23 | Loss of speech (HP:0002371) | 3.25758591 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.17202551 |
| 25 | Axonal loss (HP:0003447) | 3.11200355 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.05610053 |
| 27 | Optic neuritis (HP:0100653) | 3.05610053 |
| 28 | Gingivitis (HP:0000230) | 3.05243186 |
| 29 | Nephritis (HP:0000123) | 3.04657886 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.97202685 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.96561113 |
| 32 | Myositis (HP:0100614) | 2.93008380 |
| 33 | Recurrent viral infections (HP:0004429) | 2.91336109 |
| 34 | Pustule (HP:0200039) | 2.91291235 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.90468672 |
| 36 | Disinhibition (HP:0000734) | 2.89705249 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89098912 |
| 38 | Obstructive lung disease (HP:0006536) | 2.89098912 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.83386945 |
| 40 | Myocardial infarction (HP:0001658) | 2.82640447 |
| 41 | Joint hemorrhage (HP:0005261) | 2.73343255 |
| 42 | Colitis (HP:0002583) | 2.70928319 |
| 43 | Cellulitis (HP:0100658) | 2.70248612 |
| 44 | Periodontitis (HP:0000704) | 2.65936380 |
| 45 | Hematochezia (HP:0002573) | 2.64135962 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.60038407 |
| 47 | Mutism (HP:0002300) | 2.60002694 |
| 48 | IgM deficiency (HP:0002850) | 2.53148351 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.52059225 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51641637 |
| 51 | Increased IgE level (HP:0003212) | 2.51107629 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.50944874 |
| 53 | Increased serum ferritin (HP:0003281) | 2.50482561 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.47198438 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.43430498 |
| 56 | Chronic otitis media (HP:0000389) | 2.42242507 |
| 57 | Gingival bleeding (HP:0000225) | 2.42099798 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.38998418 |
| 59 | Petechiae (HP:0000967) | 2.38705405 |
| 60 | Epistaxis (HP:0000421) | 2.37343342 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.34493677 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.34282906 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 2.34071153 |
| 64 | Hemoptysis (HP:0002105) | 2.31317435 |
| 65 | Nuclear cataract (HP:0100018) | 2.30254141 |
| 66 | Impaired platelet aggregation (HP:0003540) | 2.29809878 |
| 67 | Abnormal platelet function (HP:0011869) | 2.29809878 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29020796 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29020796 |
| 70 | Urticaria (HP:0001025) | 2.28858494 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 2.28601701 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28300033 |
| 73 | Meningitis (HP:0001287) | 2.27818744 |
| 74 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.26882672 |
| 75 | Agnosia (HP:0010524) | 2.21971814 |
| 76 | Orchitis (HP:0100796) | 2.19276338 |
| 77 | Vasculitis (HP:0002633) | 2.18446788 |
| 78 | Pathologic fracture (HP:0002756) | 2.18259512 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.18227500 |
| 80 | Nasal polyposis (HP:0100582) | 2.17827431 |
| 81 | Osteomyelitis (HP:0002754) | 2.16997248 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.16629492 |
| 83 | Apathy (HP:0000741) | 2.15478693 |
| 84 | Diminished motivation (HP:0000745) | 2.15035843 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.14685705 |
| 86 | Menorrhagia (HP:0000132) | 2.13236915 |
| 87 | Upper motor neuron abnormality (HP:0002127) | 2.12331656 |
| 88 | Gastrointestinal stroma tumor (HP:0100723) | 2.12055757 |
| 89 | Vertebral compression fractures (HP:0002953) | 2.09449843 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 2.07034826 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.07034826 |
| 92 | Restrictive lung disease (HP:0002091) | 2.05939575 |
| 93 | Deep venous thrombosis (HP:0002625) | 2.05440035 |
| 94 | Cervical subluxation (HP:0003308) | 2.04981578 |
| 95 | Purpura (HP:0000979) | 2.04740606 |
| 96 | Encephalitis (HP:0002383) | 2.04423450 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 2.03468642 |
| 98 | Leukocytosis (HP:0001974) | 2.01455043 |
| 99 | Stomatitis (HP:0010280) | 2.00122066 |
| 100 | Joint stiffness (HP:0001387) | 1.98976250 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 1.98841846 |
| 102 | Arterial thrombosis (HP:0004420) | 1.98737539 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 1.98137908 |
| 104 | Malnutrition (HP:0004395) | 1.98127654 |
| 105 | Thrombocytosis (HP:0001894) | 1.97156368 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.94906258 |
| 107 | Personality changes (HP:0000751) | 1.93380256 |
| 108 | Retinal atrophy (HP:0001105) | 1.93202085 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93017221 |
| 110 | Xanthomatosis (HP:0000991) | 1.91572883 |
| 111 | Chest pain (HP:0100749) | 1.91498657 |
| 112 | Bone pain (HP:0002653) | 1.89569734 |
| 113 | Hypergammaglobulinemia (HP:0010702) | 1.88572438 |
| 114 | Keratoconjunctivitis (HP:0001096) | 1.88308939 |
| 115 | Arterial tortuosity (HP:0005116) | 1.87676512 |
| 116 | T lymphocytopenia (HP:0005403) | 1.87386134 |
| 117 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86851342 |
| 118 | Polygenic inheritance (HP:0010982) | 1.86302344 |
| 119 | Conjunctival telangiectasia (HP:0000524) | 1.85075716 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.82798014 |
| 121 | Thin bony cortex (HP:0002753) | 1.82275068 |
| 122 | Amyloidosis (HP:0011034) | 1.81856845 |
| 123 | Peritonitis (HP:0002586) | 1.81422184 |
| 124 | Acrocyanosis (HP:0001063) | 1.81270920 |
| 125 | Polyneuropathy (HP:0001271) | 1.80415495 |
| 126 | Esophageal varix (HP:0002040) | 1.79518852 |
| 127 | Pulmonary infiltrates (HP:0002113) | 1.75798417 |
| 128 | Deformed sella turcica (HP:0002681) | 1.74954699 |
| 129 | Ovoid vertebral bodies (HP:0003300) | 1.74355367 |
| 130 | Pulmonary embolism (HP:0002204) | 1.74280300 |
| 131 | Abnormal platelet volume (HP:0011876) | 1.72837338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.68041714 |
| 2 | MAP4K1 | 3.63034090 |
| 3 | TGFBR2 | 3.52605932 |
| 4 | ERN1 | 3.44459933 |
| 5 | PRPF4B | 3.21306183 |
| 6 | TYK2 | 2.96124598 |
| 7 | IRAK4 | 2.66917800 |
| 8 | KIT | 2.51489054 |
| 9 | CSF1R | 2.42139976 |
| 10 | TAOK3 | 2.41831464 |
| 11 | TBK1 | 2.38863851 |
| 12 | RIPK4 | 2.36808860 |
| 13 | TRIB3 | 2.21979342 |
| 14 | ZAP70 | 2.02567031 |
| 15 | STK10 | 1.90514614 |
| 16 | IRAK3 | 1.88572607 |
| 17 | EPHB1 | 1.83664815 |
| 18 | PKN2 | 1.82464874 |
| 19 | MAP2K3 | 1.81804602 |
| 20 | CSK | 1.77562313 |
| 21 | CAMK1D | 1.77396127 |
| 22 | TAOK2 | 1.77068478 |
| 23 | JAK1 | 1.70220081 |
| 24 | BTK | 1.68075805 |
| 25 | JAK3 | 1.62432793 |
| 26 | MAP3K14 | 1.61875852 |
| 27 | FES | 1.60461990 |
| 28 | HCK | 1.48595026 |
| 29 | TAOK1 | 1.47182440 |
| 30 | CDC42BPA | 1.40274036 |
| 31 | DDR2 | 1.38459076 |
| 32 | IKBKE | 1.37890281 |
| 33 | SYK | 1.36960784 |
| 34 | EEF2K | 1.36351538 |
| 35 | IKBKB | 1.30025379 |
| 36 | TEC | 1.29266453 |
| 37 | MST1R | 1.29007263 |
| 38 | LRRK2 | 1.27909156 |
| 39 | ITK | 1.27835572 |
| 40 | SMG1 | 1.27125233 |
| 41 | GRK6 | 1.24807173 |
| 42 | LCK | 1.22944420 |
| 43 | TXK | 1.21355564 |
| 44 | FGFR4 | 1.20167730 |
| 45 | CAMK1G | 1.19139656 |
| 46 | PTK6 | 1.18295761 |
| 47 | TTN | 1.16394743 |
| 48 | MAP3K1 | 1.15801648 |
| 49 | MAP3K13 | 1.13905335 |
| 50 | JAK2 | 1.13019039 |
| 51 | NEK9 | 1.12575259 |
| 52 | LYN | 1.11656568 |
| 53 | RIPK1 | 1.10294504 |
| 54 | ICK | 1.10280645 |
| 55 | TNK2 | 1.09554917 |
| 56 | FGR | 1.04225079 |
| 57 | PAK4 | 1.03833440 |
| 58 | SCYL2 | 1.01023719 |
| 59 | MATK | 1.00603639 |
| 60 | CLK1 | 0.98610984 |
| 61 | MAP3K10 | 0.98219654 |
| 62 | FLT3 | 0.92239770 |
| 63 | SIK3 | 0.89597571 |
| 64 | KDR | 0.88589576 |
| 65 | GRK7 | 0.87709119 |
| 66 | RPS6KA4 | 0.86472851 |
| 67 | NME2 | 0.80548250 |
| 68 | MAP3K3 | 0.79899485 |
| 69 | PIM2 | 0.79281129 |
| 70 | SIK2 | 0.79013484 |
| 71 | IRAK2 | 0.78761603 |
| 72 | TRPM7 | 0.77697173 |
| 73 | MARK2 | 0.75105923 |
| 74 | PIM1 | 0.71887937 |
| 75 | PRKD2 | 0.71857116 |
| 76 | MAPK7 | 0.71557498 |
| 77 | MAP3K11 | 0.67533908 |
| 78 | CDK6 | 0.67150816 |
| 79 | SIK1 | 0.66720095 |
| 80 | BMPR2 | 0.64678970 |
| 81 | KSR2 | 0.64277673 |
| 82 | FGFR3 | 0.62194043 |
| 83 | BMX | 0.62126910 |
| 84 | EGFR | 0.61450810 |
| 85 | ARAF | 0.60985183 |
| 86 | IRAK1 | 0.59346491 |
| 87 | TESK2 | 0.58490290 |
| 88 | CHUK | 0.57840384 |
| 89 | PIK3CG | 0.57448927 |
| 90 | ABL2 | 0.57134252 |
| 91 | HIPK2 | 0.55049201 |
| 92 | CAMKK2 | 0.53791372 |
| 93 | MARK3 | 0.53168353 |
| 94 | MAPKAPK3 | 0.52736101 |
| 95 | TESK1 | 0.51843074 |
| 96 | PDGFRA | 0.49384001 |
| 97 | ABL1 | 0.48847811 |
| 98 | PDK1 | 0.48502983 |
| 99 | BCKDK | 0.47643363 |
| 100 | MAP3K5 | 0.46126149 |
| 101 | MAPK12 | 0.45760171 |
| 102 | PRKCH | 0.45528525 |
| 103 | CDK12 | 0.44946056 |
| 104 | IGF1R | 0.44078089 |
| 105 | MAPK15 | 0.43692335 |
| 106 | MAPKAPK2 | 0.43577669 |
| 107 | MAPK11 | 0.43075042 |
| 108 | PRKCD | 0.42741234 |
| 109 | FYN | 0.41359291 |
| 110 | RPS6KA6 | 0.40611979 |
| 111 | PDPK1 | 0.40291338 |
| 112 | CAMKK1 | 0.39158118 |
| 113 | STK4 | 0.38415161 |
| 114 | MAPK4 | 0.36467696 |
| 115 | MAP3K8 | 0.34914029 |
| 116 | MOS | 0.34762625 |
| 117 | PRKCQ | 0.34760796 |
| 118 | RPS6KL1 | 0.32584569 |
| 119 | RPS6KC1 | 0.32584569 |
| 120 | RPS6KA2 | 0.30170641 |
| 121 | CDK4 | 0.28366653 |
| 122 | EPHA3 | 0.28006771 |
| 123 | MAP3K6 | 0.27044737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.07060674 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.98493583 |
| 3 | * Other glycan degradation_Homo sapiens_hsa00511 | 3.32738970 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 2.99697889 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89404185 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57632973 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37014829 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.29085984 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05580046 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94578248 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89828249 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.81811965 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.80225328 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78486037 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77897901 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.73087839 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.62390965 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61815727 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56606707 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55007079 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48040304 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47958454 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.45176350 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.41997817 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39599660 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36961831 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35754037 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31244593 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30067085 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27588010 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25436120 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22001008 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17840817 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17431076 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17231558 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14772620 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14491615 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.08800135 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.08350315 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06862853 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.06036413 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04259935 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03779117 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.02587720 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97814147 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.96575224 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.93704173 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90758405 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90257448 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.90185431 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87034862 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.86839725 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83888837 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83180611 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82469518 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81319124 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.80074503 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79386776 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79103490 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78964888 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.76355435 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73503743 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73072382 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72382846 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.71341552 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71179916 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70757123 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69928080 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.68171802 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67954514 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66021919 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64966650 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63828177 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62471926 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57083724 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56674888 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56628154 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.56570753 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56121396 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54225998 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52616480 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51699867 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50320290 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49827364 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49600812 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48241626 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47781922 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47769176 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.47412061 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46953501 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45843091 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45640768 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.44549808 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44501358 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43896167 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.43790182 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43719045 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.41714547 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41385259 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40823929 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40139359 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40067631 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39467891 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38687335 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38479375 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37987909 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37775394 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37011107 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35739545 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35205510 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35195243 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34017059 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33759844 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32889912 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32830415 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32329977 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32204296 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30078127 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29369822 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28960313 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28754037 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28734662 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25683635 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25526485 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24852993 |

